CXCR5 CXCL13 is elevated in various autoimmune diseases, including SLE [81], RA [82], primary Sjgrens syndrome (pSS) [83, 84], MS [85] and IBD [86]
First, there were no significant differences within minimal/mild or moderate groups when given MSG as compared to placebo, but there was a significant LS mean difference for the severe group, where higher anxiety symptoms were reported during MSG challenge as compared to placebo ( t = 2.60, p = 0.03)
This signaling platform at MERCS also serves as a critical regulator of mitochondrial quality control
195 Several systematic reviews or meta-analyses have attempted to comprehensively summarize the clinical data of GLP-1 RA in the treatment of AD or PD, but the results are still inconclusive, 196200 possibly because some clinical studies are still ongoing and require ongoing attention